David Arons is the Chief Executive Officer of the National Brain Tumor Society. He previously served in leadership and external positions at the American Cancer Society in Minnesota, the Center for Lobbying in the Public Interest and at Independent Sector. As an attorney, he previously represented patients facing disabilities and serious health conditions. He is the author of several books, including Power in Policy: A Funder’s Guide to Advocacy and Civic Participation, Strengthening Nonprofit Advocacy, and A Voice for Nonprofits. He has previously served on the National Cancer Institute’s Council of Research Advocates and Clinical Trials Advisory Committee. In 2016, Mr. Arons was named to the Blue Ribbon Panel of experts selected to help advise the National Cancer Moonshot, led by former Vice President Joseph Biden.
Chief Financial Officer
Steve Gallucci is the Chief Financial Officer of the National Brain Tumor Society. Steve brings to NBTS over twenty years of experience in financial leadership. He has served non-profits in human services, healthcare, and education, and for-profit organizations in biotech, professional services, and media. He has led organizations from startup to dramatic growth to acquisitions. Most recently, Steve served as a consulting CFO, providing expert council to senior leaders and Boards of Directors. Steve is a licensed CPA and received his MBA from Cornell University.
Lauren Hall, CFRE
Chief Development Officer
Lauren Hall is the Chief Development Officer at the National Brain Tumor Society. A senior development professional with nearly two decades of experience at some of the world’s leading institutions – including Dana-Farber Cancer Institute, the University of Pennsylvania, and Brigham and Women’s Hospital – Lauren has served as a frontline fundraiser for three multibillion-dollar campaigns. She has secured transformative funding from individuals, corporations, and foundations, built and managed boards and committees, and led highly successful fundraising teams. She previously served as Assistant Vice President of Development at Brigham and Women’s Hospital, where she directed fundraising for the neurosciences and played a key role in launching the Ann Romney Center for Neurologic Diseases.
Danielle Leach, MPA
Chief of Community & Government Relations
Danielle Leach is the Chief of Community & Government Relations at the National Brain Tumor Society. Danielle brings outstanding experience, leadership, and a track record of accomplishment to NBTS from more than two decades working in healthcare and cancer patient advocacy. Most recently, she served as Senior Director of Advocacy and Government Relations at St. Baldrick’s Foundation. Previously, she held leadership positions at the American Cancer Society, Ovarian Cancer National Alliance, and Strang Cancer Prevention Center. Additionally, she currently serves as the Co-Chair of the Alliance for Childhood Cancer, as a member of the National Cancer Institute’s (NCI) National Council of Research Advocates, and as a member of the NCI’s Pediatric and Adolescent Solid Tumor Steering Committee. She served on Vice President Biden’s Cancer Moonshot, as part of the Pediatric Cancer Working Group, and was recognized in 2018 with the ASCO Partners in Progress award and the Rare Disease Legislative Advocates Rare Voice Award.
Kirk Tanner, Ph.D
Chief Scientific Officer
Kirk Tanner is the Chief Scientific Officer at the National Brain Tumor Society. Kirk is an oncology research leader with two decades experience in discovery and development projects and programs resulting in multiple clinical candidate therapies and investigational new drugs. Formerly, he was the Research Oncology Disease Area Expert and Senior Director at Vertex Pharmaceuticals. As CSO, Kirk leads National Brain Tumor Society’s research program that aims to catalyze treatment development through philanthropic investment in medical research, engaging scientists, clinicians, patients and care partners in research programs. Kirk received his Ph.D. in chemistry from the University of California, San Diego and did post-doctoral training at Oregon Health Sciences University.
Thomas Roloff is the Chair of the National Brain Tumor Society. He is senior vice president of Information Technology & Business Transformation at Dell Technologies Corporation. He also attended the MIT Sloan School of Management where he earned an M.B.A. Mr. Roloff was also a vice president of EMC and chief operating officer at EMC Consulting. He has also held senior management positions at Perot Systems and HomeLife Medical. He earned his undergrad degree at Lafayette University and a masters degree at Virginia Tech University.
Robert Burger – Vice Chair
Robert Burger is the Vice Chair of the National Brain Tumor Society Board of Directors. He is also the Executive Director and Chief Operating Officer at the global intellectual property law firm of Sterne Kessler Goldstein & Fox headquartered in Washington, D.C. Rob is actively involved in other boards and earned his Bachelor of Arts from Miami University of Ohio, his Master’s degree from American University, and an MBA from Georgetown University. Rob’s aunt founded BTS, an NBTS legacy organization, after tragically losing her son Seth Harris Feldman to a Glioblastoma in December of 1988 (days before his 18th birthday).
John Frishkopf – Treasurer
John Frishkopf is the Treasurer of the National Brain Tumor Society Board of Directors and the Chair of the Programs Committee. He is a founder of NewStar Financial, Inc. from which he recently retired as Treasurer and Head of Asset Management. Mr. Frishkopf joined the board of NBTS after his husband, now deceased, was diagnosed with glioblastoma. A graduate of MIT and MIT Sloan, John Frishkopf has spoken at conferences and has published on using financial engineering techniques to speed the drug discovery process.
Dave Brown – Clerk
Dave Brown is the Clerk of the National Brain Tumor Society Board of Directors. He has over 30 years experience in the information industry including roles as the Global Head of Sales and Services for Clarivate Analytics, and the President and Managing Director of Thomson Reuters IP Solutions. He previously served for 10 years as a Board Member of the National Federation of Advanced Information Services. Dave has a bachelor’s degree in history and computer applications from the University of Notre Dame and an MBA from the Kenan Flagler School of Business at the University of North Carolina.
Evanthia Galanis, MD
Dr. Edjah Nduom
Eric Olson, PhD
Salo Zelermyer, JD
Co-Founder: G. Bonnie Feldman The Brain Tumor Society
Co-Founder: Walter & Ellen Newman and David & Nora Plan National Brain Tumor Foundation